Processa Pharmaceuticals, Inc.
AI summary Cluster of open-market insider purchases by multiple executives and directors.
- Research score
- 61
- AI adjustment
- +5
Research score, not a recommendation.
Market data
Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.
–
Why this score
Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.
Why are they buying?
AI · discretionary · catalyst none · documentedInsiders made recurring open-market purchases across multiple dates without an explicit company-stated catalyst or filing explanation.
Multiple directors and executive officers including the CEO and CFO acquired shares through open-market transactions, accompanied only by routine administrative amendments correcting previous share amounts.
Filing references and sources
Stock Price & Insider Purchase History
Daily close price with open-market insider purchases plotted over time
Loading price history…
Other buying runs at PCSA
A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
After this run became a cluster: 21 days -20.1%63 days -49.1%126 days -59.4%
| Window | Insiders | Total | Score | 21 days | 63 days | 126 days | Status |
|---|---|---|---|---|---|---|---|
| 2025-01-27 | 4 | $214.1K | 69 | -21.2% | -50.3% | -64.3% | closed |
| 2024-01-30 → 2024-02-07 | 4 | $160.1K | 64 | -11.2% | -15.1% | -31.6% | closed |
| 2021-06-21 → 2021-06-23 | 4 | $110.9K | 56 | -3.0% | +3.0% | -27.3% | closed |
| 2020-10-01 → 2020-10-02 | 3 | $348.4K | 42 | -12.8% | +34.4% | +60.1% | closed |